NEW YORK UNIV. v. PFIZER INC.

653590/13. 2069.

151 A.D.3d 42 (2017)

2017 NY Slip Op 03464

53 N.Y.S.3d 284

NEW YORK UNIVERSITY, Appellant, v. PFIZER INC., Respondent.

Appellate Division of the Supreme Court of New York, First Department.

Decided May 2, 2017.


Attorney(s) appearing for the Case

Lerner David Littenberg Krumholz & Mentlik LLP, Westfield, NJ ( Stephen F. Roth of the New Jersey bar, admitted pro hac vice, of counsel), and Kramer Levin Naftalis & Frankel LLP, New York City ( Michael S. Oberman and Roy H. Wepner of counsel), for appellant.

White & Case LLP, New York City ( Dimitrios T. Drivas , Christopher J. Glancy , Gregory Little and Robert Counihan of counsel), for respondent.

MAZZARELLI, J.R. and GISCHE, J., concur with ANDRIAS, J.; MOSKOWITZ and GESMER, JJ., dissent in an opinion by MOSKOWITZ, J.


OPINION OF THE COURT

In this action for breach of contract, plaintiff, New York University (NYU), seeks to recover from defendant, Pfizer, Inc., as the successor in interest to Sugen, Inc., royalties on the sale of the cancer treatment drug, Xalkori®. Xalkori®, a tyrosine kinase receptor (TKR) inhibitor, was approved...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases